The healthcare industry can make for a safe place to invest regardless of the macroeconomic conditions. It's one of the last areas where consumers would look to cut their spending for the sake of tightening up their budgets. And whether it's human health or pet health, both are options investors should consider gaining exposure to, as they could deliver surprisingly good performances in 2023.

A couple of healthcare stocks that are diversified and that could be good buys heading into the new year are AstraZeneca (NASDAQ: AZN) and PetMed Express (NASDAQ: PETS). Let's find out a bit more about these two stocks.

AstraZeneca's business performed well in 2022, but its stock isn't doing as well as perhaps it should be. Up 14% year to date, it's well outperforming the S&P 500 (which is firmly in negative territory). However, the pharmaceutical company is also trading at a forward price-to-earnings multiple of 17. That's in line with the S&P average, but this is a stock that deserves to trade at a premium given the potential it offers.

Continue reading

Source Fool.com